Park Compounding is Voluntarily Recalling One Lot of Sterile Medication

Concerns of unreliable laboratory results lead to recall

/ Author:  / Reviewed by: Joseph V. Madia, MD Beth Bolt, RPh

Park Compounding is voluntarily recalling one lot of sterile medication Testoserone Cypionate (Sesame Oil) 200mg/ml Lot [email protected] Exp: 11/3/2013 for injection in 10ml amber vials, to the consumer level.

In a recent inspection, FDA investigators observed that methods used by Front Range Laboratories to assess sterility may have resulted in pharmacies receiving inaccurate laboratory test results.

FDA has concerns that results obtained from the laboratory are not reliable.

The prescription preparations were sold during May and June of 2013, in the following states: California and Indiana.

The products would have been sold directly to customers (pick up and by mail) and to physician offices by prescription (pick up and by mail).

To date there have been no reported adverse events associated with the use of these products and there has been no confirmation of lack of sterility of these products.

If there is microbial contamination in products intended to be sterile, patients are at risk of serious infections which may be life threatening.

Therefore, Park Compounding decided to conduct this voluntary recall out of an abundance of caution.

Park Compounding is notifying its customers by phone and mail and is arranging for return of all recalled product lots.

Customers that have product which is being recalled should stop using it and contact Park Compounding to arrange for return of unused product.

Customers with questions regarding this recall can contact Park Compounding Center at 949-551-7195 or at [email protected], Monday through Friday, 9am to 5pm PST.

Customers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using these preparations.

Adverse reactions experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Review Date: 
September 10, 2013
Last Updated:
September 11, 2013